SCHEMBL17997296

SCHEMBL17997296

CCCC1CCC(C2CCC(c3ccc4cc(C)c(F)c(F)c4c3F)CC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 16/20 0.38
CYP2C9 P11712 1/20 0.33
TLR4 O00206 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13360641 0.85 OPRL1 (0.32) OPRL1CYP2C9ALDH1A1LMNAMAPT
SCHEMBL13328600 0.85 OPRL1 (0.32) OPRL1CYP2C9ALDH1A1LMNAMAPT
SCHEMBL20097358 0.83 TLR9 (0.32)
SCHEMBL17614851 0.83 OPRL1 (0.40) OPRL1CYP2C9TLR4ALDH1A1LMNA
SCHEMBL12140866 0.83 OPRL1 (0.40) OPRL1CYP2C9TLR4ALDH1A1LMNA
SCHEMBL4406898 0.83 OPRL1 (0.40) OPRL1CYP2C9TLR4ALDH1A1LMNA
SCHEMBL3437350 0.83 OPRL1 (0.40) OPRL1CYP2C9TLR4ALDH1A1LMNA
SCHEMBL13360616 0.81 OPRL1 (0.32) OPRL1CYP2C9
SCHEMBL12994006 0.81 CYP2C9 (0.42) OPRL1CYP2C9TLR4ALDH1A1LMNA
SCHEMBL13360661 0.81 OPRL1 (0.34) OPRL1CYP2C9ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3670503-B1 COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING SAME, AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD (CN) 2023-10-18 EP disclosed
US-11208395-B2 Compound, liquid crystal medium containing the compound and application thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2021-12-28 US disclosed
EP-3670503-A1 COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING SAME, AND USE THEREOF Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd. (CN) 2020-06-24 EP disclosed
US-20190345129-A1 COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2019-11-14 US disclosed
US-10351773-B2 Liquid crystal compounds of cycloalkyl-containing dibenzofuran derivatives, preparation method therefor and use thereof Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd (CN) 2019-07-16 US disclosed
US-20180112132-A1 LIQUID CRYSTAL COMPOUNDS OF CYCLOALKYL-CONTAINING DIBENZOFURAN DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD (CN) 2018-04-26 US disclosed
US-20180112132-A1 LIQUID CRYSTAL COMPOUNDS OF CYCLOALKYL-CONTAINING DIBENZOFURAN DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD (CN) 2018-04-26 US disclosed
US-9540565-B2 Liquid crystal compounds containing dibenzopyran derivatives of naphthenic base and application thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2017-01-10 US disclosed
US-9540565-B2 Liquid crystal compounds containing dibenzopyran derivatives of naphthenic base and application thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2017-01-10 US disclosed
US-20160230092-A1 LIQUID CRYSTAL COMPOUNDS CONTAINING DIBENZOPYRAN DERIVATIVES OF NAPHTHENIC BASE AND APPLICATION THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2016-08-11 US disclosed
US-20160230092-A1 LIQUID CRYSTAL COMPOUNDS CONTAINING DIBENZOPYRAN DERIVATIVES OF NAPHTHENIC BASE AND APPLICATION THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180112132-A1 LIQUID CRYSTAL COMPOUNDS OF CYCLOALKYL-CONTAINING DIBENZOFURAN DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF CYP4F11, WASF2, NOTUM OPRL1 3026/4885CYP2C9 486/4885TLR4 4273/4885
US-20190345129-A1 COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF ABCG2, TPST2, TST OPRL1 3557/4885CYP2C9 306/4885TLR4 863/4885
US-11208395-B2 Compound, liquid crystal medium containing the compound and application thereof TST, TPST2, ABCG2 OPRL1 3634/4885CYP2C9 333/4885TLR4 839/4885
US-10351773-B2 Liquid crystal compounds of cycloalkyl-containing dibenzofuran derivatives, preparation method therefor and use thereof CYP4F11, WASF2, NOTUM OPRL1 3026/4885CYP2C9 486/4885TLR4 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.